Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Pharmacology Pubmed

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

Varga, K; Lake, K; Martin, B R; Kunos, G
European Journal of Pharmacology , Volume 278 (3): 5 – Dec 12, 1995
Download PDF

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

Varga, K; Lake, K; Martin, B R; Kunos, G
European Journal of Pharmacology , Volume 278 (3): 5 – Dec 12, 1995

Loading next page...
 
/lp/pubmed/novel-antagonist-implicates-the-cb1-cannabinoid-receptor-in-the-nwTuLU2jcx

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0014-2999
DOI
10.1016/0014-2999(95)00181-j
pmid
7589169

Abstract

Journal

European Journal of Pharmacology – Pubmed

Published: Dec 12, 1995

There are no references for this article.